Literature DB >> 18432418

Neuroscience and hormesis: overview and general findings.

Edward J Calabrese1.   

Abstract

This article provides a summary of an assessment of the occurrence and impact of hormesis in the neurosciences, including the areas of neuroprotection, neurite outgrowth, and drugs for Alzheimer's disease, Parkinson's disease, anxiety, pain, seizures, stroke, as well as in the areas of behavioral pharmacology, addictive drugs, stress biology including the Yerkes-Dodson law, and p-glycoprotein efflux activity. The findings indicate that the hormetic dose response has a common, if not dominant, presence in each of these diverse areas of neuroscience and further strengthens the conclusion that hormesis is highly generalizable, being independent of biological model, endpoint, and chemical class.

Entities:  

Mesh:

Year:  2008        PMID: 18432418     DOI: 10.1080/10408440801981957

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  28 in total

1.  Hormesis pervasiveness and its potential implications for pharmaceutical research and development.

Authors:  Kenneth I Maynard
Journal:  Dose Response       Date:  2011-07-29       Impact factor: 2.658

Review 2.  Modulation of Nrf2/ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders.

Authors:  Giovanni Scapagnini; Sonya Vasto; Vasto Sonya; Nader G Abraham; Abraham G Nader; Calogero Caruso; Caruso Calogero; Davide Zella; Galvano Fabio
Journal:  Mol Neurobiol       Date:  2011-04-19       Impact factor: 5.590

3.  A perspective on the scientific, philosophical, and policy dimensions of hormesis.

Authors:  George R Hoffmann
Journal:  Dose Response       Date:  2009-01-19       Impact factor: 2.658

Review 4.  Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders.

Authors:  Vittorio Calabrese; Carolin Cornelius; Albena T Dinkova-Kostova; Edward J Calabrese; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2010-08-28       Impact factor: 8.401

5.  Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes.

Authors:  Vittorio Calabrese; Carolin Cornelius; Anna Maria Giuffrida Stella; Edward J Calabrese
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

Review 6.  Small molecule modulators of Keap1-Nrf2-ARE pathway as potential preventive and therapeutic agents.

Authors:  Sadagopan Magesh; Yu Chen; Longqin Hu
Journal:  Med Res Rev       Date:  2012-05-01       Impact factor: 12.944

Review 7.  Research review: maternal prenatal distress and poor nutrition - mutually influencing risk factors affecting infant neurocognitive development.

Authors:  Catherine Monk; Michael K Georgieff; Erin A Osterholm
Journal:  J Child Psychol Psychiatry       Date:  2012-10-05       Impact factor: 8.982

Review 8.  Hurdles to clear before clinical translation of ischemic postconditioning against stroke.

Authors:  Heng Zhao
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

Review 9.  Associations of welding and manganese exposure with Parkinson disease: review and meta-analysis.

Authors:  James A Mortimer; Amy R Borenstein; Lorene M Nelson
Journal:  Neurology       Date:  2012-09-11       Impact factor: 9.910

10.  Using hormetic strategies to improve ischemic preconditioning and postconditioning against stroke.

Authors:  Heng Zhao; Sungpil Joo; Weiying Xie; Xunming Ji
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2013-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.